Splicing modulation of ATXN2 as a therapeutic strategy to regulate Ataxin-2 protein levels in ALS.

Heinsinger N, Wang Y, Grauer S, Zhang Z, Wong J, Simov V, Bukhtiyarova M, Ai X, Parish C, Klein RM, Uslaner J, Smith S, Tian Y

Open source

DOI
10.1016/j.nbd.2026.107582
Published
2026 Aug 24
Container
Neurobiology of disease
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.nbd.2026.107582,
  title = {Splicing modulation of ATXN2 as a therapeutic strategy to regulate Ataxin-2 protein levels in ALS.},
  author = {Heinsinger N and Wang Y and Grauer S and Zhang Z and Wong J and Simov V and Bukhtiyarova M and Ai X and Parish C and Klein RM and Uslaner J and Smith S and Tian Y},
  year = {2026},
  journal = {Neurobiology of disease},
  doi = {10.1016/j.nbd.2026.107582},
  url = {https://doi.org/10.1016/j.nbd.2026.107582}
}

RIS

TY  - JOUR
TI  - Splicing modulation of ATXN2 as a therapeutic strategy to regulate Ataxin-2 protein levels in ALS.
AU  - Heinsinger N
AU  - Wang Y
AU  - Grauer S
AU  - Zhang Z
AU  - Wong J
AU  - Simov V
AU  - Bukhtiyarova M
AU  - Ai X
AU  - Parish C
AU  - Klein RM
AU  - Uslaner J
AU  - Smith S
AU  - Tian Y
PY  - 2026
JO  - Neurobiology of disease
DO  - 10.1016/j.nbd.2026.107582
UR  - https://doi.org/10.1016/j.nbd.2026.107582
ER  - 

APA

N, H., Y, W., S, G., Z, Z., J, W., V, S., M, B., X, A., C, P., RM, K., J, U., S, S., & Y, T. (2026). Splicing modulation of ATXN2 as a therapeutic strategy to regulate Ataxin-2 protein levels in ALS.. Neurobiology of disease. https://doi.org/10.1016/j.nbd.2026.107582

Source records